Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
33M
-
Number of holders
-
264
-
Total 13F shares, excl. options
-
30.5M
-
Shares change
-
-448K
-
Total reported value, excl. options
-
$2.55B
-
Value change
-
-$50.2M
-
Put/Call ratio
-
1.52
-
Number of buys
-
128
-
Number of sells
-
-140
-
Price
-
$83.54
Significant Holders of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) as of Q4 2022
325 filings reported holding AMED - AMEDISYS INC - Common Stock, par value $0.001 per share as of Q4 2022.
AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) has 264 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.5M shares
of 33M outstanding shares and own 92.42% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.11M shares), VANGUARD GROUP INC (3.13M shares), WELLINGTON MANAGEMENT GROUP LLP (2.8M shares), JPMORGAN CHASE & CO (1.76M shares), RIVERBRIDGE PARTNERS LLC (1.53M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.14M shares), AMERIPRISE FINANCIAL INC (1.08M shares), MACKENZIE FINANCIAL CORP (1.04M shares), STATE STREET CORP (894K shares), and Bellevue Group AG (614K shares).
This table shows the top 264 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.